Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05419128 · ClinicalTrials.gov registry record · NA
Family-focused vs. Drinker-focused Smartphone Interventions to Reduce Drinking-related Consequences of COVID-19
A NA study of Alcohol Use Disorder and Family Members, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 398
- Enrollment target
- 1
- Study location
NCT05419128: Completed NA study of Alcohol Use Disorder and Family Members, sponsored by University of Wisconsin, Madison.
NCT05419128 is a NA study of Alcohol Use Disorder and Family Members that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 398 participants, above the 326-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (22% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05419128, a NA study of Alcohol Use Disorder and Family Members, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 398 participants
- Enrollment target
- 1
- Study location
Study Summary
This R01 project titled "Family-focused vs. Drinker-focused Smartphone Interventions to Reduce Drinking-related Consequences of COVID-19" is a Hybrid II RCT/implementation study to modify and test two of our alcohol smartphone interventions to address the fallout from COVID. We propose a three-arm RCT comparing a smartphone control group vs. a drinker-focused intervention vs. a family-focused intervention. All study arms recruit dyads comprising a person who drinks and a family partner.
Primary Outcome
Risky drinking day will be defined as greater than 4 drinks for men and greater than 3 drinks for women and will be measured through the Timeline Followback every 120 days. 8 months was the end of the intervention, 12 months was the final follow-up (4 months after the intervention ended).
Conditions Studied
Interventions
- BEHAVIORAL PartnerCHESS
- BEHAVIORAL ACHESS
Study Locations (1)
Wisconsin
- University of Wisconsin - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 398 participants |
| Start Date | 2022-04-06 |
| Est. Completion | 2024-07-17 |
| Phase | NA |
What the finished NCT05419128 record still lists
NCT05419128 is an interventional study that assigns participants to a tested intervention. The registered 398 participants enrollment target is mid-sized for trials with a published cap, above the 326-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (22% higher).
The record links to 3 conditions, with Alcohol Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which PartnerCHESS is the first listed.
NCT05419128 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT05419128 about?
NCT05419128 is a clinical study titled "Family-focused vs. Drinker-focused Smartphone Interventions to Reduce Drinking-related Consequences of COVID-19". This R01 project titled "Family-focused vs. Drinker-focused Smartphone Interventions to Reduce Drinking-related Consequences of COVID-19" is a Hybrid II RCT/implementation study to modify and test two of our alcohol smartphone interventions to address the fallout from COVID. We propose a three-arm R...
What is the current status of trial NCT05419128?
This trial is currently completed. It is a NA study. The enrollment target is 398 participants. The study started on 2022-04-06. Estimated completion is 2024-07-17.
What conditions does trial NCT05419128 study?
This clinical trial studies the following conditions: Alcohol Use Disorder, Family Members, Behavior, Addictive.
What interventions are being tested in trial NCT05419128?
The interventions under investigation include: PartnerCHESS (BEHAVIORAL), ACHESS (BEHAVIORAL).
Who is sponsoring clinical trial NCT05419128?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05419128 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05419128's enrollment target sits among peer trials
398 24th of 184 higher than 161 of 184 other Alcohol Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ultrasound Neuromodulation of the Brain for Alcohol Use Disorder
RECRUITING · NA
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
RECRUITING · NA
-
AAT for Alcohol Use Disorder in Veterans
RECRUITING · NA
-
Testing a PTSD m-Health Intervention to Improve Alcohol Treatment Outcomes
RECRUITING · NA
-
Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05365581 · 398 participants · Phase 1
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
- NCT03165734 · 399 participants · Phase 3
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
- NCT05022862 · 399 participants · NA
Economic Incentives and vDOT for Latent Tuberculosis Infection
- NCT00601939 · 397 participants · NA
Effectiveness of Empowerment Group Sessions for Treating Suicidal African American Women in Abusive Relationships
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI